SCM
BIIB icon

Stonebridge Capital Management’s Biogen BIIB Stock Holding History

Stonebridge Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,682
Closed -$634K – 142
2019
Q1 		$634K Buy
2,682
+21
+0.8% +$6.61K 0.23% 73
2018
Q4 		$800K Sell
2,661
-65
-2% -$20.7K 0.32% 64
2018
Q3 		$964K Sell
2,726
-35
-1% -$12.1K 0.33% 60
2018
Q2 		$825K Buy
2,761
+100
+4% +$28.1K 0.3% 66
2018
Q1 		$707K Sell
2,661
-75
-3% -$23.3K 0.26% 68
2017
Q4 		$919K Sell
2,736
-1,738
-39% -$558K 0.33% 60
2017
Q3 		$1.4M Sell
4,474
-705
-14% -$209K 0.53% 46
2017
Q2 		$1.41M Buy
5,179
+1,880
+57% +$497K 0.54% 46
2017
Q1 		$902K Buy
3,299
+2,314
+235% +$654K 0.36% 55
2016
Q4 		$279K Buy
+985
New +$292K 0.12% 97

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stonebridge Capital Management's BIIB Position: Q2 2019 in Review

Stonebridge Capital Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 2,682 shares — an estimated $634K sold.

Stonebridge Capital Management first reported a position in BIIB in Q4 2016 and held it in 10 quarters. The position peaked at $1.41M in Q2 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Stonebridge Capital Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Stonebridge Capital Management sold 2,682 Biogen shares in Q2 2019, an estimated $634K.
  • Stonebridge Capital Management first reported a position in Biogen in Q4 2016 and held it in 10 quarters.
  • Stonebridge Capital Management's Biogen position peaked at $1.41M in Q2 2017.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Stonebridge Capital Management's 13F filing for Q2 2019, filed 12 Jul 2019.